PIEDMONT INVESTMENT ADVISORS INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q3 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2019$613,000
+18.3%
18,462
+3.7%
0.02%0.0%
Q4 2018$518,000
-31.5%
17,808
+8.3%
0.02%
-21.9%
Q3 2018$756,000
-71.2%
16,440
-76.6%
0.03%
-74.6%
Q2 2018$2,623,000
+28.8%
70,179
+1.9%
0.13%
+133.3%
Q1 2018$2,036,000
-13.1%
68,894
+1.0%
0.05%
+14.9%
Q4 2017$2,344,000
-6.0%
68,236
-1.0%
0.05%
-11.3%
Q3 2017$2,493,000
-25.8%
68,912
-47.0%
0.05%
-29.3%
Q2 2017$3,360,000
+107.0%
130,025
+53.9%
0.08%
+120.6%
Q1 2017$1,623,000
-99.7%
84,513
+131.7%
0.03%
+183.3%
Q4 2016$608,071,000
+121.5%
36,477
+173.5%
0.01%
+100.0%
Q3 2016$274,496,000
+31967.3%
13,338
+47535.7%
0.01%
Q2 2016$856,000
-18.3%
280.0%0.00%
Q1 2016$1,048,000
-13.2%
280.0%0.00%
Q4 2015$1,208,000
+15.2%
280.0%0.00%
Q3 2015$1,049,000
+10.3%
280.0%0.00%
Q2 2015$951,000
-4.0%
280.0%0.00%
Q1 2015$991,000
+4.0%
280.0%0.00%
Q4 2014$953,000
-50.6%
28
-44.0%
0.00%
Q3 2014$1,928,000
+5.4%
50
+6.4%
0.00%
Q2 2014$1,829,000
+13.9%
470.0%0.00%
Q1 2014$1,606,000
-32.2%
47
-58.4%
0.00%
Q4 2013$2,370,000
+620.4%
113
+707.1%
0.00%
Q3 2013$329,000140.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,309,206$109,866,0006.94%
SG Capital Management LLC 604,159$20,058,0003.66%
KESTREL INVESTMENT MANAGEMENT CORP 232,975$7,735,0003.57%
Broadfin Capital, LLC 500,000$16,600,0003.43%
Tieton Capital Management, LLC 98,199$3,260,0002.90%
SG Capital Management LLC 350,000$11,620,0002.12%
DISCIPLINED GROWTH INVESTORS INC /MN 2,852,064$94,689,0001.66%
Broadfin Capital, LLC 240,000$7,968,0001.64%
Millrace Asset Group, Inc. 58,302$1,936,0001.63%
PURA VIDA INVESTMENTS, LLC 300,000$9,960,0001.42%
View complete list of MYRIAD GENETICS INC shareholders